Ehud Ur, an endocrinologist in Vancouver, said Wegovy allows Novo Nordisk "to segment out the two markets for obesity and diabetes." "But, you know, they're intimately related," said Ur, who is not affiliated with Novo Nordisk
A 2019 network meta-analysis of 233 trials (n = 147,710) reported elevated risks of dizziness (odds ratios [ORs] 1.92, 1.57, 1.40) and headache (ORs 1.34, 1.41, 1.18) with GLP-1 RAs versus insulin, thiazolidinediones, and placebo 40
The New England Journal of Medicine , 384, 9891002
Dialyse Da L-Carnitin wasserlslich ist und ber den Harnstoff ausgeschieden wird, fhrt die Blutwsche hufig zu einem Mangel
Concerns around potential side effects are a known reason people choose not to take GLP-1 drugs